alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                                                                               .
                                                                               .
                                                                               .

                      WOLVERINE TUBE, INC. AND SUBSIDIARIES
                    EXHIBIT 21 -- SUBSIDIARIES OF REGISTRANT

<TABLE>
<CAPTION>
                                                  State or Other Jurisdiction of
                Name                                      Incorporation
-------------------------------------------       ------------------------------
<S>                                               <C>
Small Tube Manufacturing, LLC                               Delaware
Tube Forming, LP                                            Delaware
Wolverine Europe (EURL)                                     France
Wolverine Europe Holdings, B.V.                             The Netherlands
Wolverine Finance Company, LLC                              Tennessee
Wolverine Joining Technologies, LLC                         Delaware
Wolverine Joining Technologies Canada, Inc.                 Canada
Wolverine Tube Europe B.V.                                  The Netherlands
Wolverine Tube, B.V.                                        The Netherlands
Wolverine Tube (Canada) Inc.                                Canada
Wolverine Tube (Shanghai) Co. Ltd.                          China
Wolverine Tubagem Portugal, LDA                             Portugal
TF Investor, Inc.                                           Delaware
Tube Forming Holdings, Inc.                                 Delaware
WT Holding Company, Inc.                                    Delaware
3072996 Nova Scotia Company                                 Nova Scotia
3072452 Nova Scotia Company                                 Nova Scotia
3072453 Nova Scotia Company                                 Nova Scotia
Wolverine Tube Canada Limited Partnership                   New Brunswick
Wolverine China Investments, LLC                            Delaware
WLVN de Latinoamerica, S. de R.L. de C.V.                   Mexico
WLV Mexico, S. de R.L. de C.V.                              Mexico
</TABLE>
```

[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[S. 1459 Introduced in Senate (IS)]

105th CONGRESS
  1st Session
                                S. 1459

    To amend the Internal Revenue Code of 1986 to provide a 5-year 
extension of the credit for producing electricity from wind and closed-
                             loop biomass.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            November 8, 1997

Mr. Grassley (for himself, Mr. Jeffords, Mr. Murkowski, Mr. Conrad, Mr. 
  Harkin, Mr. Kerrey of Nebraska, Mrs. Feinstein, Mrs. Boxer, and Mr. 
   Johnson) introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
    To amend the Internal Revenue Code of 1986 to provide a 5-year 
extension of the credit for producing electricity from wind and closed-
                             loop biomass.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 5-YEAR EXTENSION OF CREDIT FOR PRODUCING ELECTRICITY FROM 
              WIND AND BIOMASS.

    Paragraph (3) of section 45(c) of the Internal Revenue Code of 1986 
(defining qualified facility) is amended by striking ``1999'' and 
inserting ``2004''.
                                 <all>
```
```

[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[S. 1229 Introduced in Senate (IS)]

105th CONGRESS
  1st Session
                                S. 1229

   To provide for the conduct of a clinical trial concerning digital 
                              mammography.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           September 26, 1997

 Mr. Campbell introduced the following bill; which was read twice and 
         referred to the Committee on Labor and Human Resources

_______________________________________________________________________

                                 A BILL

 
   To provide for the conduct of a clinical trial concerning digital 
                              mammography.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. OFFICE OF RESEARCH ON WOMEN'S HEALTH CLINICAL TRIAL OF 
              DIGITAL MAMMOGRAPHY.

    (a) In General.--The Office of Research on Women's Health, acting 
through the Assistant Secretary for Health, shall award grants under 
this section for the conduct of a large-scale clinical trial of digital 
mammography.
    (b) Contract.--In carrying out subsection (a), the Office of 
Research on Women's Health shall enter into a contract with the Multi-
Agency Consortium on Imaging Technologies to Improve Women's Health for 
the solicitation, acceptance and processing of competitive grant 
applications.
    (c) Requirements.--In providing for the conduct of a clinical trial 
under this section the Office of Research on Women's Health shall 
ensure that--
            (1) at least 50,000 women are tested under this study;
            (2) at least 20 institutions are involved in the testing; 
        and
            (3) at least 2,500 conventional and 2,500 digital 
        mammographies will be conducted at each institution.
    (d) Authorization of Appropriations.--There is authorized to be 
appropriated $20,000,000 to carry out this section.
                                 <all>
```
#### Bernard Cherry, Appellant, v Koehler & Isaacs LLP et al., Respondents.

[945 NYS2d 878]

— Order, Supreme Court, Bronx County (Wilma Guzman, J.), entered on or about October 26, 2010, which granted defendants’ motion to dismiss the complaint pursuant to CPLR 3211 (a) (7), unanimously affirmed, without costs.

The motion court properly concluded that this action could not be maintained against defendants, the counsel hired by plaintiff’s union to represent him in the disciplinary proceedings prior to his termination from the Department of Correction *(see Mamorella v Derkasch,*276 AD2d 152, 155 [2000]).

We have considered plaintiffs remaining contentions, including that he himself had retained defendants, and find them unavailing. Concur — Saxe, J.P., Catterson, Acosta, DeGrasse and Richter, JJ.
Amendment No. 1 to Facility Agreement



 Exhibit 4.4 
 AMENDMENT NO. 1 TO FACILITY AGREEMENT 
 This AMENDMENT NO. 1 TO FACILITY AGREEMENT (this
“Amendment No. 1”), dated as of October 22, 2008, is made by and among ZymoGenetics, Inc. and Deerfield Private Design Fund, L.P. and Deerfield Private Design International, L.P. (together the “Original Deerfield
Lenders”) and Deerfield ZG Corporation (“DZG”). 
 W I T N E S S E T H 
 WHEREAS, the parties hereto other than DZG have entered into the Facility Agreement, dated June 26, 2008 (the “FA”); and

 WHEREAS, the parties to this Amendment No. 1 desire to amend the FA to add Deerfield ZG as a party thereto; 
 NOW, THEREFORE, the parties hereto agree as follows: 
 1. Deerfield ZG shall become a party to the FA and the definition of “Lenders” shall include the Original Deerfield Lenders and DZG; provided, however, that for the purposes of Sections 2.11 and 5.4, the
definition of “Lenders” shall not include DZG. 
 2. For the purpose of Section 3.3, DZG shall not make the representations
and warranties set forth in paragraphs (a) through (g) but shall make the representations and warranties set forth in paragraphs (h) through (k) mutatis mutandis (e.g., in paragraph (h) DZG is a corporation).

 3. The last sentence of Section 2.2 shall be deleted and replaced with the following: 
 “For the purpose of the first paragraph of the Notes, each Disbursement shall be allocated 61.7% to Deerfield Private Design
International, L.P. and 38.3% to Deerfield Private Design Fund, L.P.” 
 4. Except as amended hereby, the FA shall remain in full force
and effect. 
 Signature page follows. 







 IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 1 to be signed as of the date
first above written. 
  

									
	 BORROWER:
 ZYMOGENETICS, INC.
	 		 	 LENDER:
 DEERFIELD PRIVATE
DESIGN FUND, L.P.

					
	 By:
	 	 /s/    James A. Johnson
	 		 	By:	 	 /s/    James Flynn

	 Name:
	 	James A. Johnson	 		 	Name:	 	James Flynn
	 Title:
	 	 Executive Vice President and
 Chief Financial Officer

	 		 	Title:	 	General Partner

  

			
	 LENDER:
 DEERFIELD PRIVATE DESIGN
 INTERNATIONAL, L.P.

		
	 By:
	 	 /s/    James Flynn

	 Name:
	 	James Flynn
	 Title:
	 	General Partner

  

			
	 LENDER:
 DEERFIELD ZG CORPORATION

		
	 By:
	 	 /s/    James Flynn

	 Name:
	 	James Flynn
	 Title:
	 	General Partner
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Soil Management and Sugarbeet Research: Fort Collins, CO
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                                    Software
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Plains Area Fort Collins, Colorado Center for Agricultural Resources Research Soil Management and Sugarbeet Research People & Locations







Rebecca  Hutchens
                        Soil Management and Sugarbeet Research

                        




                        
                        Program Support Assistant (Office Automation)
                        Phone: (970) 266-6280
                        
                        
                        Fax: (Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual
Report of Wolverine Tube, Inc. (the Company) on Form 10-K for the period ending December 31, 2007 as filed with the Securities and Exchange Commission (the Report), I, Harold M. Karp, Principal Executive Officer of
Wolverine Tube, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to Wolverine Tube, Inc. and will be retained by Wolverine Tube, Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.



/s/ Harold M. KarpHarold M. KarpPrincipal Executive OfficerPresident and Chief Operating OfficerJune 11, 2009




108
[Federal Register Volume 86, Number 153 (Thursday, August 12, 2021)]
[Notices]
[Pages 44377-44378]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17212]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Delegation of Authority

    Notice is hereby given that I have delegated to the Administrator, 
Health Resources and Services Administration (HRSA), or their 
successor, the authorities that are vested in the Secretary of Health 
and Human Services under section 1150C of the Social Security Act (42 
U.S.C. 1301 et seq.), as added by section 9911 of the American

[[Page 44378]]

Rescue Plan Act of 2021 (Pub. L. 117-2). This authorizes the HRSA 
Administrator, on behalf of the Secretary, to make payments to rural 
providers and suppliers for health care related expenses and lost 
revenues that are attributable to COVID-19. This delegation does not 
confer authority to issue regulations. These authorities may be 
redelegated.
    This delegation of authority is effective upon date of signature.

    Dated: August 9, 2021.
Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2021-17212 Filed 8-11-21; 8:45 am]
BILLING CODE 4150-03-P
[Federal Register Volume 86, Number 155 (Monday, August 16, 2021)]
[Notices]
[Page 45750]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17504]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to The National Cooperative Research and 
Production Act of 1993--Medical CBRN Defense Consortium

    Notice is hereby given that, on July 1, 2021, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense Consortium 
(``MCDC'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing changes in 
its membership. The notifications were filed for the purpose of 
extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, American Type Culture Collection, Manassas, VA; Bugworks 
Research, Inc., Fremont, CA; and Indiana University, Bloomington, IN; 
Jubilant HollisterStier, Spokane, WA; Lumen Bioscience, Inc., Seattle, 
WA; MBio Diagnostics, Inc. dba LightDeck Diagnostics, Boulder, CO; UES, 
Inc., Dayton, OH; Vaxess Technologies, Inc., Cambridge, MA; Vector RX 
LLC, Elkridge, MD and VitriVax, Inc., Boulder, CO have been added as 
parties to this venture.
    Also, Kestrel Corporation, Albuquerque, NM, has withdrawn as a 
party to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MCDC intends to file additional 
written notifications disclosing all changes in membership.
    On November 13, 2015, MCDC filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
January 6, 2016 (81 FR 513).
    The last notification was filed with the Department on March 29, 
2021. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on April 20, 2021 (86 FR 20521).

Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2021-17504 Filed 8-13-21; 8:45 am]
BILLING CODE 4410-11-P
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Livestock, Forage and Pasture Management Research Unit: El Reno, OK
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Plains Area El Reno, Oklahoma Oklahoma and Central Plains Agricultural Research Center Livestock, Forage and Pasture Management Research Unit People & Locations







Katherine Ann Angelopoulos

(Kate)
                        Livestock, Forage and Pasture Management Research Unit

                        




                        
                        Biological Science Technician
                        Phone: (405) 262-5291
                        
                        
                        Fax: (405) 262-0133(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
#### The People of the State of New York, Respondent, v Patrick Morrison, Appellant.

Appeal by defendant from a judgment of the Supreme Court, Queens County (Dufficy, J.), rendered May 17, 1983, convicting him of murder in the second degree (two counts), robbery in the first degree, and criminal possession of a weapon in the second degree, upon a jury verdict, and imposing sentence. The appeal brings up for review the denial, after a hearing, of a motion by defendant to suppress identification testimony.

Judgment affirmed.

On appeal, defendant contends that the in-court identification by the witness, Philip Dennis, should have been suppressed because the People failed to prove by clear and convincing evidence that the identification was based upon a source independent from the witness’s observations at a photographic identification procedure. We disagree. The record reveals that this witness had ample opportunity to observe defendant from a relatively close range, for approximately 30 minutes. Moreover, there is no evidence in the record to indicate that Mr. Dennis’ in-court identification emanated from anything other than his independent recollection of defendant as the perpetrator of the crime. In addition to the identification by Mr. Dennis, defendant was positively identified by three other eyewitnesses, one of whom had known defendant for two months prior to the incident. The quantum as well as consistency of the identification testimony elicited from the various witnesses was clearly sufficient to establish defendant’s guilt.

Defendant also alleges that he was deprived of a fair trial by several instances of prosecutorial misconduct. After reviewing each of the allegations, we have reached the conclusion that whether considered singly, or in combination, these alleged errors did not operate to deprive defendant of a fair trial.

We have considered defendant’s remaining contentions and *673find them to be without merit. Mangano, J. P., Bracken, Niehoff and Eiber, JJ., concur.
EXHIBIT 31.1CERTIFICATIONI, Jeffrey I. Dreben, certify that:1. I have reviewed this report on Form 10-QSB of CVF Technologies Corporation; 2. Based on my knowledge, this quarterly report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in lightof the circumstances under which such statements were made, not misleading with respect to theperiod covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)for the registrant and have: a. designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under our supervision,to ensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is beingprepared;  b. evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report based on such evaluation; and  c. disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter (the registrant’s fiscal fourthquarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing the equivalentfunctions): a. all significant deficiencies and material weaknesses in thedesign or operation of which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financialinformation; and  b. any fraud, whether or not material, that involves managementor other employees who have a significant role in the registrant’s internalcontrol over financial reporting.   Date: November 14, 2005    /s/ Jeffrey I. Dreben     Jeffrey I. Dreben,  Chief Executive Officer